MARKET RADAR
SENSEX     NIFTY      Refresh
Moneycontrol.com India | Notes to Account > Food Processing > Notes to Account from Indo Biotech Foods - BSE: 519222, NSE: INDBIOFOOD
YOU ARE HERE > MONEYCONTROL > MARKETS > FOOD PROCESSING > NOTES TO ACCOUNTS - Indo Biotech Foods
Indo Biotech Foods
BSE: 519222|NSE: INDBIOFOOD|ISIN: INE183C01012|SECTOR: Food Processing
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
Indo Biotech Foods is not traded in the last 30 days
Indo Biotech Foods is not traded in the last 30 days
« Sep 10
Notes to Accounts Year End : Sep '11
1.  Previous year figures have been regrouped, whenever necessary.
 
 2.  Balances of Sundry Debtors, Loan & Advances and current liabilities
 are subject to confirmation, adjustment and pending reconciliation.
 
 3.  Additional information pursuant to the provisions of Part II of
 Schedule VI of The Companies Act. 1956 to the extent applicable as
 certified by the Management.
 
 (a) Capacity and Production.
 
 Note: The Consumption does not include wastage, testing and analysis of
 Nil.
 
 (c) The details regarding Utilization, Licensed Capacity etc. are not
 applicable.
 
 (d) Expenditure in Foreign Currency: Rs. Nil (Previous year Nil)
 
 (e) C.I.F. Value of imports: Capital Goods: Rs. Nil (Previous year
 Rs. Nil)
 
 (f) Earnings in foreign exchange : Rs. Nil (Previous year Nil)
 
 4.  There are no amounts overdue and remaining unpaid to small scale
 and/or Ancillary Industrial suppliers.
 
 5.  Rs. 29,414,338/- Unsecured Loan includes interest free loan from a
 Company in which a Director is interested (Previous year Rs.
 30,253,517/-)
 
 6.  No cost rules have been prescribed by Central Government under
 section 209(1 )(d) of the Companies Act, 1956.
 
 7.  The Company dose not provide for retirement benefits such as
 gratuity and leave encashment. It is amounted on cash basis at the time
 of payment to the employees on retirement.
 
 8.  Impairment in the carrying value of the office equipment is
 recognized in accordance with Accounting Standard - 28, Impairment of
 Assets.
 
 9.  Earnings per Share (EPS) computed in accordance with AS-20 :
 Eating''s per Share
 
 10.  As a matter of prudence and due to no virtual certainty of
 reversal of the deferred tax asset in future, the same has not been
 accounted by the Company.
 
 We have examined the above Cash Flow Statement of Indo Biotech Foods
 Ltd for the year ended 30th September. 2011. The statement has been
 prepared by the Company in accordance with the requirements of Clause
 32 of Listing Agreement with Stock Exchanges and is based on and is in
 agreement with the books and the records of the Company and also the
 Profit and Loss account and Balance Sheet of the Company covered by our
 Report of even date to the members of the Company.
Source : Dion Global Solutions Limited
Quick Links for indobiotechfoods
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.